Search | Page 18 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Eculizumab Protects Against TE and Prolongs Survival in Patients with Paroxysmal Nocturnal Hemoglobinuria: An International PNH Registry Study

    ... likely to have thromboembolism were those who had recent red blood cell transfusions, a history of liver problems, and headaches. ...

    Research Review last updated 05/02/2016 - 9:26am.

  2. A Study of Luspatercept (ACE-536) to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MEDALIST)

    ... IN SUBJECTS WITH RING SIDEROBLASTS WHO REQUIRE RED BLOOD CELL TRANFUSIONS Status:  ...

    Clinical Trial last updated 04/21/2016 - 1:16pm.

  3. Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes

    ... phase II trial studies how well donor umbilical cord blood transplant with or without ex-vivo expanded cord blood progenitor ... may help the patient's bone marrow make stem cells, red blood cells, white blood cells, and platelets. It is not yet known whether ...

    Clinical Trial last updated 04/27/2016 - 1:17pm.

  4. What is MDS? iPad App

    ... materials provide information about why MDS results in low blood counts, such as anemia (low red blood cell count), neutropenia (low white blood cell ...

    Page last updated 10/28/2015 - 2:31pm.

  5. Disease Won't Run My Life

    ... care physician. One day later, after receiving a blood test, my physician called and instructed me to have someone drive me ... the nurse began transfusing the first of three units of red blood cells, doctors began coming in to meet the woman “whose blood ...

    Patient Chronicle last updated 05/10/2016 - 3:36pm.

  6. Safety and Efficacy of Oral Azacitidine (CC-486) Administered in Extended Treatment Schedules to Patients with Lower-Risk Myelodysplastic Syndromes

    ... enrolling patients with lower-risk MDS who need regular red blood cell transfusions, have thrombocytopenia (low platelet ...

    Research Review last updated 05/02/2016 - 9:27am.

  7. Supportive Care

    ... is not a cure. This approach includes the use of: Blood transfusions Iron chelation therapy to treat iron ... treatment can work. Aplastic anemia patients may get red blood cell transfusions or platelet transfusions. Iron ...

    Page last updated 08/29/2013 - 4:20pm.

  8. EHA S826: Eltrombopag Added to Standard Immunosuppression as First Treatment in Severe Aplastic Anemia

    ... is immunosuppressive treatment. This treatment improves blood cell counts in about 60% to 65% of patients with severe aplastic anemia. ... a median 32 days of treatment. They stopped needing red blood cell transfusions after a median 39 days of treatment. Three ...

    Research Review last updated 05/02/2016 - 9:10am.

  9. Darbepoetin Alfa

    ... agents (ESAs). Darbepoetin alfa can help improve red blood cell counts in bone marrow failure patients whose natural ...

    Drug last updated 03/24/2016 - 12:32pm.

  10. Epoetin Alfa

    ... Epoetin alfa can help improve red blood cell counts in bone marrow failure disease patients whose ...

    Drug last updated 03/24/2016 - 12:32pm.